World's Best Scientists 2026 revealed!
Alfredo Carrato

Alfredo Carrato

D-Index & Metrics

Medicine

D-Index
76
Citations
23302
World Ranking
18719
National Ranking
264

Overview

Alfredo Carrato is affiliated with the University of Alcalá in Spain. Their research spans multiple disciplines within medicine and molecular biology, with a primary focus on oncology and cancer research.

The scientist's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Carrato has contributed extensively to subfields such as:

  • Oncology
  • Cancer Research
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Surgery

Científico's research covers several key topics, showing a broad interest in cancer types and related biological mechanisms. The main topics of work include:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Pancreatitis Pathology and Treatment
  • Epigenetics and DNA Methylation
  • Gastric Cancer Management and Outcomes

Recent notable papers authored or co-authored by Carrato include:

  • "A faecal microbiota signature with high specificity for pancreatic cancer," 2022, Gut
  • "ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity," 2020, Nature Communications
  • "Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients," 2021, Molecular Cancer
  • "Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals," 2021, Gastroenterology
  • "Tyrosine Kinase Receptors in Oncology," 2020, International Journal of Molecular Sciences

Carrato frequently publishes in several key scientific venues, which include:

  • Pancreatology
  • Cancers
  • Annals of Oncology
  • Journal of Clinical Oncology
  • Gut

Throughout their career, Carrato has often collaborated with a group of frequent co-authors, indicating ongoing research partnerships. These collaborators include:

  • Julie Earl
  • Núria Malats
  • Francisco X. Real
  • Xavier Molero
  • Thomas M. Gress

Best Publications

  • Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

    Chris Twelves;Alfred Wong;Marek P. Nowacki;Markus Abt

  • NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

    Montserrat García-Closas;Núria Malats;Debra Silverman;Mustafa Dosemeci

  • Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

    Cristina M. Villanueva;Kenneth P. Cantor;Joan O. Grimalt;Nuria Malats

  • Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

    Felipe Cardenal;M. Paz López-Cabrerizo;Antonio Antón;Vicente Alberola

  • A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

    Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

  • Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

    Michael Goggins;Kasper Alexander Overbeek;Randall Brand;Sapna Syngal

  • Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

    Silvia Hernández;Elena López-Knowles;Josep Lloreta;Manolis Kogevinas

  • Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

    Bernard Nordlinger;Eric Van Cutsem;Philippe Rougier;Claus Henning Köhne

  • HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

    Angela N. Bartley;Mary Kay Washington;Carol Colasacco;Christina B. Ventura

  • Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

    Eduardo Díaz-Rubio;Jose Tabernero;Auxiliadora Gómez-España;Bartomeu Massutí

  • Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage

    Miquel Porta;Xavier Fabregat;Núria Malats;Luisa Guarner

  • Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers

    Hans Vasen;Isaura Ibrahim;Carmen Guillen Ponce;Emily P. Slater

  • Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

    Cristina Balbás-Martínez;Ana Sagrera;Enrique Carrillo-de-Santa-Pau;Julie Earl

  • Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.

    Yves Allory;Willemien Beukers;Ana Sagrera;Marta Flández

  • Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

    Lee E Moore;Ruth M Pfeiffer;Cristina Poscablo;Francisco X Real

  • Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.

    V. Alberola;C. Camps;M. Provencio;D. Isla

  • A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

    A Carrato;A Falcone;M Ducreux;Juan W Valle

  • PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.

    Elena López-Knowles;Silvia Hernández;Núria Malats;Manolis Kogevinas

  • Polymorphisms in GSTT1, GSTZ1, AND CYP2E1, disinfection by-products, and risk of bladder cancer in Spain

    Kenneth P. Cantor;Cristina M. Villanueva;Debra T. Silverman;Jonine D. Figueroa

  • Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer

    Miquel Porta;Núria Malats;Manuel Jariod;Joan O Grimalt

Frequent Co-Authors

Núria Malats
Núria Malats Spanish National Cancer Research Centre
Francisco X. Real
Francisco X. Real Pompeu Fabra University
Manolis Kogevinas
Manolis Kogevinas Pompeu Fabra University
Debra T. Silverman
Debra T. Silverman National Institutes of Health
Nathaniel Rothman
Nathaniel Rothman National Institutes of Health
Montserrat Garcia-Closas
Montserrat Garcia-Closas National Institutes of Health
Stephen J. Chanock
Stephen J. Chanock National Institutes of Health
Mustafa Dosemeci
Mustafa Dosemeci National Institutes of Health
Rafael Rosell
Rafael Rosell Autonomous University of Barcelona
David J. Hunter
David J. Hunter Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are passionate about healthcare but looking for flexible learning options, several online degrees offer great alternatives to a traditional Medicine pathway in the USA. For those interested in mental health, consider enrolling in the fastest pmhnp program. This accelerated path helps you become a mental health nurse practitioner in less time.

For individuals aspiring to management roles, earning an online healthcare administration degree or pursuing a master's in healthcare administration online can be excellent choices. These programs combine core medical knowledge with business skills, preparing graduates for leadership in hospitals, clinics, or public health organizations.

Advanced nursing professionals may consider the convenience of a 1 year dnp program online, which delivers a Doctor of Nursing Practice degree in a significantly reduced timeframe. Exploring these related online degrees can open doors to rewarding medical and healthcare careers, often with faster completion and more affordable tuition than traditional routes.

Best Scientists Citing Alfredo Carrato

Trending Scientists

Recently Published Articles